DRI Healthcare Trust

The Trust is managed by DRI Capital Inc., the pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the Trust has deployed more than $1.0 billion, acquiring more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To learn more, visit drihealthcare.com or follow us on LinkedIn.



Contact Information
David Levine, Director, Investor Relations
Tel: (416) 324-5738
[email protected]

Latest

Mar 05, 2025, 08:10 ET Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

TORONTO, March 5, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN/DHT.U) ("DRI" or "the Trust") today informs its unitholders of an adjustment to its previously announced quarterly cash distribution...

Mar 03, 2025, 17:29 ET DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

Remediation of material weaknesses complete 45% increase in Normalized Total Cash Receipts over the prior year showcases continued execution and growth of portfolio Announcing 2025 royalty income...

Jan 29, 2025, 07:00 ET DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

TORONTO, Jan. 29, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces...

Dec 20, 2024, 07:00 ET DRI Healthcare Trust Declares Special Unit Distribution

TORONTO, Dec. 20, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces...

Nov 06, 2024, 17:00 ET DRI Healthcare Trust Reports Third Quarter 2024 Results

53% adjusted EBITDA growth over prior year period shows strong focus on cash generation Recent acquisitions and credit facility expansion highlight growth under new leadership TORONTO, Nov. 6, 2024...

Nov 04, 2024, 07:06 ET DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista...

– First pre-approval royalty acquisition and first equity investment highlight evolving investment strategy – – Up to US$184 million investment brings capital deployment to over US$1 billion since...

Nov 01, 2024, 09:07 ET DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities

– Enhances deployment capacity without increasing leverage parameters – – Sufficient funding to achieve 2025 deployment target – – Marginal decrease in interest rate and standby fees – TORONTO, Nov....

Oct 11, 2024, 11:30 ET DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024

TORONTO, Oct. 11, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its third quarter 2024 financial...

Oct 03, 2024, 18:00 ET DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)

– Transaction adds another innovative rare disease therapy to the DHT portfolio – – Novel deal structure offers predictable annual cash flows as well as potential additional annual sales-based...

Aug 06, 2024, 17:01 ET DRI Healthcare Trust Reports Second Quarter 2024 Results

– Highest Normalized Total Cash Receipts in a single quarter since IPO, excluding milestones – – Trust internal investigation substantially complete with no impact to cash royalty receipts – – New...

Jul 03, 2024, 10:30 ET DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024

TORONTO, July 3, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its second quarter 2024 financial results on...

Jul 02, 2024, 07:00 ET DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

– Transaction pushes total committed capital to over US$1 billion since IPO – – Second Xenpozyme royalty increases exposure to rare diseases – – Long-term asset further increases portfolio duration – ...

May 07, 2024, 12:18 ET DRI Healthcare Trust Announces Voting Results of AGM

TORONTO, May 7, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held...

May 06, 2024, 17:00 ET DRI Healthcare Trust Reports First Quarter 2024 Results

– Highest quarterly Adjusted EBITDA since IPO underscores continued execution of growth strategy – – Omidria expansion transaction highlights strong execution capabilities – – Simplifying capital...

Apr 23, 2024, 17:31 ET DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities

– Transaction significantly reduces potential dilution with a net reduction of warrants equivalent to 8.2% of units outstanding – TORONTO, April 23, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN)...

Apr 16, 2024, 10:00 ET DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 7, 2024

TORONTO, April 16, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its first quarter 2024 financial results on...

Apr 15, 2024, 07:00 ET DRI Healthcare Trust Announces Refinancing of Preferred Securities

– Transaction reduces the Trust's potential unit dilution by 8.2% by retiring in-the-money warrants and replacing them with out-of-the-money warrants – TORONTO, April 15, 2024 /CNW/ - DRI Healthcare...

Mar 26, 2024, 10:30 ET DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

TORONTO, March 26, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) ( TSX: DHT.U) ("DRI" or the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry,...

Feb 28, 2024, 17:00 ET DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results

– 82% royalty income growth over prior year period underscores transformative year – – Announcing 2024 royalty income guidance of US$153 to US$155 million, excluding milestone income and any new...

Feb 08, 2024, 10:30 ET DRI Healthcare Trust to Host Fourth Quarter and Full Year 2023 Earnings Call and Webcast on February 29, 2024

TORONTO, Feb. 8, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its fourth quarter and full year 2023 financial...

Feb 01, 2024, 09:31 ET DRI Healthcare Trust Announces the Expansion of its Royalty Entitlement on the US Net Sales of Omidria®, Updates Deployment and CAGR Guidance

– Immediate and accretive cash flow generation replaces structured annual caps – – Increasing capital deployment guidance to over US$1.25 billion deployed for the five years ending 2025 – – Now...

Dec 20, 2023, 17:00 ET DRI Healthcare Trust Declares Special Distributions

TORONTO, Dec. 20, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), today announced that, its Board of Trustees has declared a special cash distribution in the amount of...

Nov 13, 2023, 17:00 ET DRI Healthcare Trust Reports Third Quarter 2023 Results

– 36% royalty income growth over prior year period highlights successful portfolio growth strategy – – Significant deployment capacity available after follow-on offerings and credit facility increase ...

Oct 31, 2023, 07:48 ET DRI Healthcare Trust Announces Upsized US$500 Million Credit Facilities

– Significantly enhances deployment capacity without increasing leverage parameters – TORONTO, Oct. 31, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in...

Oct 24, 2023, 10:30 ET DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 14, 2023

TORONTO, Oct. 24, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its third quarter 2023 financial results on...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE